Also found in: Dictionary, Thesaurus, Wikipedia.


trademark for a preparation of ceftriaxone sodium, a cephalosporin antibiotic.

ceftriaxone sodium


Pharmacologic class: Third-generation cephalosporin

Therapeutic class: Anti-infective

Pregnancy risk category B

GI: nausea, vomiting, diarrhea, abdominal cramps, oral candidiasis, pseudomembranous colitis, pancreatitis, Clostridium difficile-associated diarrhea


Interferes with bacterial cell-wall synthesis and division by binding to cell wall, causing cell to die. Active against gram-negative and gram-positive bacteria, with expanded activity against gram-negative bacteria. Exhibits minimal immunosuppressant activity.


Powder for injection: 250 mg, 500 mg, 1 g, 2 g

Premixed containers: 1 g/50 ml, 2 g/50 ml

Indications and dosages

Infections of respiratory system, bones, joints, and skin; septicemia
Adults: 1 to 2 g/day I.M. or I.V. or in equally divided doses q 12 hours. Maximum daily dosage is 4 g.

Uncomplicated gonorrhea
Adults: 250 mg I.M. as a single dose

Surgical prophylaxis
Adults: 1 g I.V. as a single dose within 1 hour before start of surgical procedure

Adults: 1 g to 2 g I.V. q 12 hours for 10 to 14 days
Children: Initially, 100 mg/kg/day I.M. or I.V. (not to exceed 4 g). Then 100 mg/kg/day I.M. or I.V. once daily or in equally divided doses q 12 hours (not to exceed 4 g) for 7 to 14 days.

Otitis media
Children: 50 mg/kg I.M. as a single dose; maximum of 1 g/dose.

Skin and skin-structure infections
Children: 50 to 75 mg/kg/day I.V. or I.M. once or twice daily. Maximum dosage is 2 g daily.

Other serious infections
Children: 50 to 75 mg/kg/day I.V. or I.M. once or twice daily

Dosage adjustments

• Hepatic dysfunction with significant renal impairment

Off-label uses

• Disseminated gonorrhea
• Endocarditis
• Epididymitis
• Gonorrhea-associated meningitis
• Lyme disease
Neisseria meningitides carriers
• Pelvic inflammatory disease


• Neonates (28 days or younger)


Use cautiously in:
• hypersensitivity to cephalosporins or penicillins, allergies
• renal impairment, hepatic disease, gallbladder disease, phenylketonuria
• history of GI disease, diarrhea following antibiotic therapy
• pregnant or breastfeeding patients.


• Obtain specimens for culture and sensitivity testing as necessary before starting therapy.

Be aware that drug mustn't be given with or within 48 hours of calcium-containing I.V. solutions, including calcium-containing continuous infusions such as parenteral nutrition, because of risk of precipitation of ceftriaxone calcium salt (particularly in neonates).
• Know that drug for I.V. injection is compatible with sterile water, normal saline solution, dextrose 5% in water (D5W), half-normal saline solution, and D5W and normal saline solution.
• After reconstituting, dilute further to desired concentration for intermittent I.V. infusion. Infuse over 30 minutes.
• For I.M. use, reconstitute powder for injection with compatible solution by adding 0.9 ml of diluent to 250-mg vial, 1.8 ml to 500-mg vial, 3.6 ml to 1-g vial, or 7.2 ml to 2-g vial, to yield a concentration averaging 250 mg/ml.
• Divide high I.M. doses equally and administer in two separate sites. Inject deep into large muscle mass.

Adverse reactions

CNS: headache, confusion, hemiparesis, lethargy, paresthesia, syncope, seizures

CV: hypotension, palpitations, chest pain, vasodilation

EENT: hearing loss

GI: nausea, vomiting, diarrhea, abdominal cramps, oral candidiasis, pseudomembranous colitis, pancreatitis, Clostridium difficile-associated diarrhea

GU: vaginal candidiasis

Hematologic: lymphocytosis, eosinophilia, bleeding tendency, hemolytic anemia, hypoprothrombinemia, neutropenia, thrombocytopenia, agranulocytosis, bone marrow depression

Hepatic: jaundice, hepatomegaly

Musculoskeletal: arthralgia

Respiratory: dyspnea

Skin: urticaria, maculopapular or erythematous rash

Other: chills, fever, superinfection, pain at I.M. injection site, anaphylaxis, serum sickness


Drug-drug.Aminoglycosides, loop diuretics: increased risk of nephrotoxicity

Calcium-containing solutions: possibly fatal reactions caused by ceftriaxone calcium precipitates

Probenecid: decreased excretion and increased blood level of ceftriaxone

Drug-diagnostic tests.Alanine aminotransferase, alkaline phosphatase, aspartate aminotransferase, bilirubin, blood urea nitrogen, creatinine, eosinophils, gamma-glutamyltransferase, lactate dehydrogenase: increased levels
Coombs' test, urinary 17-ketosteroids, nonenzyme-based urine glucose tests (such as Clinitest): false-positive results

Hemoglobin, platelets, white blood cells: decreased values

Drug-herbs.Angelica, anise, arnica, asafetida, bogbean, boldo, celery, chamomile, clove, danshen, fenugreek, feverfew, garlic, ginger, ginkgo, ginseng, horse chestnut, horseradish, licorice, meadowsweet, onion, papain, passionflower, poplar, prickly ash, quassia, red clover, turmeric, wild carrot, wild lettuce, willow: increased risk of bleeding.

Patient monitoring

Monitor for extreme confusion, tonic-clonic seizures, and mild hemiparesis when giving high doses.
• Monitor coagulation studies.
• Assess CBC and kidney and liver function test results.
• Monitor for signs and symptoms of superinfection and other serious adverse reactions.
• Be aware that cross-sensitivity to penicillins and cephalosporins may occur.

Patient teaching

• Instruct patient to report persistent diarrhea, bruising, or bleeding.
• Caution patient not to use herbs unless prescriber approves.
• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs, tests, and herbs mentioned above.


A trademark for the drug ceftriaxone sodium.


a trademark for a cephalosporin antibiotic (ceftriaxone sodium).


Ceftriaxone Infectious disease An antibiotic for acute bacterial otitis media in children. See Cephalsporine.


A brand name for CEFTRIAXONE.
References in periodicals archive ?
I've had my eyes opened by David Marks (one of the past presidents of ILADS) and his experience of curing himself of ALS on very low doses of Rocephin.
Case study analysis of lifecycle management strategies for Zithromax (Pfizer), Rocephin (Roche) and Biaxin (Abbott) and assessment of their success
The report examines the outlook for branded Rocephin in the key US market discussion of Sandoz, Lupin, and Hospira strategies for generic ceftriaxone.
In the CABP trials, the comparator antibacterial treatment was Rocephin (ceftriaxone) and in the ABSSSI trials, the comparator antibacterial treatment was Vancocin (vancomycin) plus Azactam (aztreonam).
In the CABP trials, 1,231 adult patients received Teflaro or Rocephin.
Products in the Company's portfolio include key brands such as Rocephin, Bactrim, Lexotan, Rivotril as well as UnaSyn and Vibramycin.
Stack worked in Roche's United States pharmaceutical business from 1981 to 1993 and held a variety of operational and management positions including sales, product management with major brands such as Rocephin and Zantac, and leadership of Roche's worldwide Infectious Disease, Oncology and Virology business strategy.
This product is AP rated and is equivalent to Rocephin by Roche.
New services being launched at RediClinic during the next 30 days include: steroid injections for allergy relief; Rocephin antibiotic treatment for common bacterial infections; B-12 shots for an energy boost; mononucleosis testing; and acne treatment.
Rocephin is a prime example of increased generic pressure as the product was once the leading cephalosporin antibiotic product on the market with more than $1 billion in annual sales.
Over the past 30 years as Medical Director and then Managing Director of Roche companies in New Zealand, the United Kingdom and California, Dr Taylor has been involved in the clinical development of multiple commercialized drugs: Madopar and Tasmar for the treatment of Parkinson's Disease, and Pulmozyme, Roferon, Rocephin, and Xenical among others.